Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series ; volume:6 ; number:1 ; day:11 ; month:10 ; year:2018 ; pages:1-9 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (11.10.2018), 1-9, 12.2018
- Creator
-
Moseley, Kendall F.
- Contributor
-
Naidoo, Jarushka
Bingham, Clifton O.
Carducci, Michael A.
Forde, Patrick M.
Gibney, Geoffrey T.
Lipson, Evan J.
Shah, Ami A.
Sharfman, William H.
Cappelli, Laura C.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0417-8
- URN
-
urn:nbn:de:101:1-2018111918504854033447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moseley, Kendall F.
- Naidoo, Jarushka
- Bingham, Clifton O.
- Carducci, Michael A.
- Forde, Patrick M.
- Gibney, Geoffrey T.
- Lipson, Evan J.
- Shah, Ami A.
- Sharfman, William H.
- Cappelli, Laura C.
- SpringerLink (Online service)
Other Objects (12)
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Preliminary analysis of immune-related markers in thymic carcinoid
Integrated analysis of immune-related genes in endometrial carcinoma
Corticosteroid-resistant immune-related adverse events: a systematic review
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Preliminary analysis of immune-related markers in thymic carcinoid
Integrated analysis of immune-related genes in endometrial carcinoma
Corticosteroid-resistant immune-related adverse events: a systematic review
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Preliminary analysis of immune-related markers in thymic carcinoid
Integrated analysis of immune-related genes in endometrial carcinoma